Latest Shareholder Approval News

Shriro Holdings updates shareholders on proposed buy-backs that could reshape voting power, with major stakes changing hands and key players abstaining from votes.

Nutritional Growth Solutions (ASX – NGS) has locked in a $2 million capital raise through a share placement aimed at fueling sales, inventory, and growth initiatives, pending shareholder approval.

Oceana Lithium has appointed seasoned executives Michael Wilson and Sam Brooks to its leadership team, signaling a strategic pivot towards gold, silver, and copper exploration and acquisitions. A proposed name change to Oceana Metals Limited underscores this new direction.

Bellavista Resources has appointed former De Grey Mining executives Glenn Jardine and Peter Canterbury as Managing Director and Finance Director, aiming to leverage their proven track records to accelerate exploration and development.

RocketDNA has raised $4 million through a well-supported placement to accelerate production and software development, following significant contract wins with mining giants BHP Mitsubishi Alliance and Gold Fields.

West Cobar Metals has raised $1.5 million through a discounted share placement to fund key exploration and testwork at its critical minerals projects, signalling renewed momentum in its development pipeline.

Eastern Metals is progressing its acquisition of Raptor Resources and has agreed to sell its Browns Reef Project, while planning a $4-5 million capital raise pending shareholder approval.

AMA Group Limited reported a robust FY25 with a 38.4% rise in normalized EBITDA and significant net debt reduction, setting a confident tone for FY26. Operational improvements across key divisions underpin the company’s optimistic outlook.

Skin Elements Limited reports successful completion of key product evaluations and secures $2.5 million placement to fuel growth and commercialisation in 2026.

Metal Bank Limited is advancing its Western Australia gold strategy with significant resource development at Livingstone and a binding agreement to acquire Hastings Technology Metals’ WA gold assets, while also progressing critical minerals projects in Queensland and Saudi Arabia.

Argent BioPharma has secured a transformative acquisition of AusCann’s core assets, bolstering its drug delivery technology and manufacturing capabilities ahead of a planned U.S. listing. The company also reported key clinical milestones and refinancing moves in its September 2025 quarterly update.

Lodestar Minerals reports promising gold drilling results at Ned’s Creek, advances exploration in Chile, and announces a strategic acquisition of a US rare earth project.